News | Stroke | January 15, 2024

Goldstein Selected to Help Lead Statewide Task Force Addressing Heart Disease and Stroke

Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology.

Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology. Photo by Shaun Ring.


January 15, 2024 — Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology, has been selected to serve as co-chair of The Kentucky Heart Disease and Stroke Prevention (KHDSP) Task Force representing stroke systems of care across the state. 

Goldstein is co-director of the Kentucky Neuroscience Institute, co-director of the UK Neuroscience Research Priority Area, contact PI for the state’s CDC Coverdell National Acute Stroke Program grant, and interim director of the UK-Norton Healthcare Stroke Care Network. Additionally, he also sits on the board of directors of The American Academy of Neurology (AAN)

With his focus on the stroke systems of care throughout Kentucky, Goldstein will lead the task force alongside Nathan Kusterer, M.D., a cardiologist with Baptist Health, who represents the state’s heart systems of care. 

The task force works in partnership with the Kentucky Department for Public Health’s Heart Disease and Stroke Prevention Program. The collaborative group was developed in 2006 to address cardiovascular disease in the Commonwealth. The task force is comprised of a diverse group of stakeholders committed to improving the health of Kentuckians. The initial membership included 27 individuals representing 14 agencies; the task force currently has 419 members representing 194 different agencies.

“Through our work on Kentucky's CDC Coverdell National Acute Stroke Program, I have been working with the KHDSP Task Force to advance stroke prevention and care throughout Kentucky,” said Goldstein. “This is another opportunity to coordinate and leverage efforts to reduce the burden of stroke statewide.”

The task force is represented by health systems, emergency medical organizations, community-based, professional and voluntary health organizations, businesses, higher level educational institutes and local and state government agencies. 

“The KHDSP brings together stroke and heart disease expertise and efforts to impact both conditions across the state.  It is a particularly important approach for improving public health by addressing commonalities between heart disease and stroke,” said Goldstein.

The goal of the Task Force is to improve Kentucky’s cardiovascular and cerebrovascular health. “It is wonderful to have the opportunity to lead and work with a group of passionate, dedicated colleagues focused on making our state healthier,” said Goldstein. 

For more information: https://www.uky.edu/


Related Content

News | Stroke

March 10, 2026 — Medtronic has entered into a definitive agreement to acquire Scientia Vascular, a company with critical ...

Home March 12, 2026
Home
News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Home March 11, 2026
Home
News | Stroke

Feb. 6, 2026 — Rapid Medical, a developer of active endovascular devices, has announced the latest results from the ...

Home February 10, 2026
Home
News | Stroke

Feb. 2, 2026 — Brainomix, a provider of AI-powered imaging tools in stroke and lung fibrosis, is introducing its new ...

Home February 02, 2026
Home
News | Stroke

Jan. 13, 2026 — A streamlined, nurse-led response for hospitalized patients experiencing an acute stroke at a Texas ...

Home January 15, 2026
Home
News | Stroke

Dec. 3, 2025 — Recross Cardio Inc., a structural heart company developing next-generation membrane sealing technology ...

Home December 04, 2025
Home
News | Stroke

Dec. 2, 2025 — Brainomix, a provider of AI-powered imaging tools in stroke and lung fibrosis, has announced the ...

Home December 03, 2025
Home
News | Stroke

Nov. 10, 2025 — Sentante, a med-tech robotics company, has successfully demonstrated a first-of-a-kind remote stroke ...

Home November 10, 2025
Home
News | Stroke

Oct. 22, 2025 — Basking Biosciences, a clinical-stage biopharmaceutical company developing the first reversible ...

Home October 22, 2025
Home
News | Stroke

Oct. 21, 2025 — At the seventeenth edition of the World Stroke Congress in Barcelona, Siemens Healthineers will present ...

Home October 21, 2025
Home
Subscribe Now